Stock Research for PSDV

PSDV

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

PSDV Stock Chart & Research Data

The PSDV chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PSDV chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


PSDV Due diligence Resources & Stock Charts

The PSDV stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PSDV Detailed Price Forecast - CNN Money CNN View PSDV Detailed Summary - Google Finance
Yahoo View PSDV Detailed Summary - Yahoo! Finance Zacks View PSDV Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View PSDV Trends & Analysis - Trade-Ideas Barrons View PSDV Major Holders - Barrons
NASDAQ View PSDV Call Transcripts - NASDAQ Seeking View PSDV Breaking News & Analysis - Seeking Alpha
Spotlight View PSDV Annual Report - CompanySpotlight.com OTC Report View PSDV OTC Short Report - OTCShortReport.com
TradeKing View PSDV Fundamentals - TradeKing Charts View PSDV SEC Filings - Bar Chart
WSJ View Historical Prices for PSDV - The WSJ Morningstar View Performance/Total Return for PSDV - Morningstar
MarketWatch View the Analyst Estimates for PSDV - MarketWatch CNBC View the Earnings History for PSDV - CNBC
StockMarketWatch View the PSDV Earnings - StockMarketWatch MacroAxis View PSDV Buy or Sell Recommendations - MacroAxis
Bullish View the PSDV Bullish Patterns - American Bulls Short Pains View PSDV Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View PSDV Stock Mentions - StockTwits PennyStocks View PSDV Stock Mentions - PennyStockTweets
Twitter View PSDV Stock Mentions - Twitter Invest Hub View PSDV Investment Forum News - Investor Hub
Yahoo View PSDV Stock Mentions - Yahoo! Message Board Seeking Alpha View PSDV Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for PSDV - SECform4.com Insider Cow View Insider Transactions for PSDV - Insider Cow
CNBC View PSDV Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PSDV - OTC Markets
Yahoo View Insider Transactions for PSDV - Yahoo! Finance NASDAQ View Institutional Holdings for PSDV - NASDAQ


Stock Charts

FinViz View PSDV Stock Insight & Charts - FinViz.com StockCharts View PSDV Investment Charts - StockCharts.com
BarChart View PSDV Stock Overview & Charts - BarChart Trading View View PSDV User Generated Charts - Trading View


Latest Financial News for PSDV

EyePoint Pharmaceuticals Announces Third Quarter Fiscal Year 2018 Financial Results Release Date and Conference Call Information
Posted on Thursday April 19, 2018

EyePoint Pharmaceuticals, Inc. (EYPT) (ASX:PVA), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, will report results for its third quarter of fiscal year 2018 on Tuesday, May 8, 2018.  Management will host a conference call to review the results at 4:30 p.m. ET on the same day. The conference ID is 1758647. A live webcast will be available on the Investor Relations section of the corporate website at http://www.eyepointpharma.com.


EyePoint Pharmaceuticals’ YUTIQ™ for Posterior Segment Uveitis to be Presented at the 2018 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Posted on Wednesday April 18, 2018

WATERTOWN, Mass., April 18, 2018-- EyePoint Pharmaceuticals, a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced that two abstracts ...


EyePoint Pharmaceuticals Strengthens Global IP with Notices of Allowance for Two U.S. Patents Related to DEXYCU™
Posted on Thursday April 12, 2018

WATERTOWN, Mass., April 12, 2018-- EyePoint Pharmaceuticals, Inc., a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced that ...


pSivida Corp. Announces Transformative Acquisition of Icon Bioscience Inc. and Growth Capital Financing with Essex Woodlands Healthcare Partners – Company Will Rebrand as EyePoint Pharmaceuticals, Inc.
Posted on Wednesday March 28, 2018

Acquisition and additional funding significantly accelerate the company’ s transformation to a specialty biopharmaceutical company with the potential to commercialize two ophthalmic products in 1 H 2019. ...


Enter a stock symbol to view the stock details.